Kdd2点cn污「一度もやらなかった」と彼女は言ってため息をついた。「ホテルに着いて鞄をよっこらしょと置いたとたんに生理が始まっちゃったのcどっと」　　推进中国式现代化是一个系统工程，需要统筹兼顾、系统谋划、整体推进。要正确处理好顶层设计与实践探索的关系。进行顶层设计，需要深刻洞察世界发展大势，准确把握人民群众的共同愿望，深入探索经济社会发展规律，使制定的规划和政策体系体现时代性、把握规律性、富于创造性，做到远近结合、上下贯通、内容协调。推进中国式现代化作为一项探索性事业，还有许多未知领域，需要我们在实践中大胆探索，决不能刻舟求剑、守株待兔。要正确处理好战略与策略的关系。要增强战略的前瞻性、全局性和稳定性，准确把握事物发展的必然趋势，以科学的战略预见未来、引领未来，在谋划战略目标、制定战略举措、作出战略部署时，要着眼于解决事关党和国家事业兴衰成败、牵一发而动全身的重大问题。而且战略一经形成，就要长期坚持、一抓到底、善作善成，不要随意改变。同时，要把战略的原则性和策略的灵活性有机结合起来，灵活机动、随机应变、临机决断，在因地制宜、因势而动、顺势而为中把握战略主动。vPDf-qWFyOVLNtNDevfUv-安进公司（纳斯达克股票代码：AMGN）是值得拥有的高质量股票吗？

Many investors are st ill learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). By way of learning-by-doing, we'll look at ROE to gain a better understanding of Amgen Inc. (NASDAQ:AMGN).

Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. Simply put, it is used to assess the profitability of a company in relation to its equity capital.

How To Calculate Return On Equity?

ROE can be calculated by using the formula:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for Amgen is:

75% = US$3.8b ÷ US$5.0b (Based on the trailing twelve months to March 2024).

The 'return' is the yearly profit. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.75.

Does Amgen Have A Good ROE?

One simple way to determine if a company has a good return on equity is to compare it to the average for its industry. Importantly, this is far from a perfect measure, because companies differ significantly within the same industry classification. Pleasingly, Amgen has a superior ROE than the average (15%) in the Biotechs industry.

NasdaqGS:AMGN Return on Equity May 27th 2024

That is a good sign. With that said, a high ROE doesn't always indicate high profitability. Especially when a firm uses high levels of debt to finance its debt which may boost its ROE but the high leverage puts the company at risk. Our risks dashboardshould have the 3 risks we have identified for Amgen.

The Importance Of Debt To Return On Equity

Companies usually need to invest money to grow their profits. The cash for investment can come from prior year profits (retained earnings), issuing new shares, or borrowing. In the case of the first and second options, the ROE will reflect this use of cash, for growth. In the latter case, the use of debt will improve the returns, but will not change the equity. That will make the ROE look better than if no debt was used.

Combining Amgen's Debt And Its 75% Return On Equity

It appears that Amgen makes extensive use of debt to improve its returns, because it has an alarmingly high debt to equity ratio of 12.75. While its ROE is no doubt quite impressive, it could give a false impression about the company's returns given that its huge debt could be boosting those returns.

Conclusion

Return on equity is a useful indicator of the ability of a business to generate profits and return them to shareholders. In our books, the highest quality companies have high return on equity, despite low debt. If two companies have the same ROE, then I would generally prefer the one with less debt.

But when a business is high quality, the market often bids it up to a price that reflects this. Profit growth rates, versus the expectations reflected in the price of the stock, are a particularly important to consider. So you might want to check this FREE visualization of analyst forecasts for the company.

But note: Amgen may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.